PVRL2 Is translocated to the TRA@ locus in t(14; 19)(q11;q13)-positive peripheral T-cell lymphomas

Genes Chromosomes and Cancer

Volumn 46, Issue 11, 2007, Pages 1011-1018

  Almire, Carole ^a   Bertrand, Philippe ^a   Ruminy, Philippe ^a   Maingonnat, Catherine ^a   Wlodarska, Iwona ^b   Martín Subero, José I ^c   Siebert, Reiner ^c   Tilly, Hervé ^a   Bastard, Christian ^a  

^a CENTRE HENRI BECQUEREL   (France)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BCL3 GENE; CASE REPORT; CHROMOSOME 14Q; CHROMOSOME 19Q; CHROMOSOME TRANSLOCATION 14; CHROMOSOME TRANSLOCATION 19; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE LOCUS; HUMAN; HUMAN TISSUE; MALE; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PVRL2 GENE; T CELL LYMPHOMA; TELOMERE;

BASE SEQUENCE; CELL ADHESION MOLECULES; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 19; CLONING, MOLECULAR; DNA PRIMERS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOMA, T-CELL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSLOCATION, GENETIC;

EID: 34848897863     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20490     Document Type: Article

References (27)

1. Akasaka T, Balasas T, Russell LJ, Sugimoto KJ, Majid A, Walewska R, Karran EL, Brown DG, Cain K, Harder L, Gesk S, Martin-Subero JI, Atherton MG, Bruggemann M, Calasanz MJ, Davies T, Haas OA, Hagemeijer A, Kempski H, Lessard M, Lillington DM, Moore S, Nguyen-Khac F, Radford-Weiss I, Schoch C, Struski S, Talley P, Welham MJ, Worley H, Strefford JC, Harrison CJ, Sieben R, Dyer MJ. 2007. Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Blood 109:3451-3461.
2. Bertrand P, Courel MN, Maingonnat C, Jardin F, Tilly H, Bastard C. 2005. Expression of HYAL2 mRNA, hyaluronan and hyaluronidase in B-cell non-Hodgkin lymphoma: Relationship with tumor aggressiveness. Int J Cancer 113:207-212.
3. Bertrand P, Bastard C, Maingonnat C, Jardin F, Maisonneuve C, Courel MN, Ruminy P, Picquenot JM, Tilly H. 2007. Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas. Leukemia 21:515-523.
4. Bondarenko VA, Liu YV, Jiang YI, Studitsky VM. 2003. Communication over a large distance: Enhancers and insulators. Biochem Cell Biol 81:241-251.
5. Canoz O, Rassidakis GZ, Admirand JH, Medeiros LJ. 2004. Immunohistochemical detection of BCL-3 in lymphoid neoplasms: A survey of 353 cases. Mod Pathol 17:911-917.
6. Chapiro E, Russell L, Radford-Weiss I, Bastard C, Lessard M, Struski S, Cave H, Fert-Ferrer S, Barin C, Maarek O, Della-Valle V, Strefford JC, Berger R, Harrison CJ, Bernard OA, Nguyen-Khac F. 2006. Overexpression of CEBPA resulting from the translocation t(14;19)(q32;q13) of human precursor B acute lymphoblastic leukemia. Blood 108:3560-3563.
7. Gesk S, Martin-Subero JI, Harder L, Luhmann B, Schlegelberger B, Calasanz MJ, Grote W, Siebert R. 2003. Molecular cytogenetic detection of chromosomal breakpoints in T-cell receptor gene loci. Leukemia 17:738-745.
8. Graf M, Reif S, Hecht K, Kroell T, Nuessler V, Schmelzer H. 2005. Expression of poliovirus receptor-related proteins PRR1 and PRR2 in acute myeloid leukemia: first report of surface marker analysis, contribution to diagnosis, prognosis and implications for future therapeutical strategies. Eur J Haematol 75:477-484.
9. Jaffe ES, Harris NL, Stein H, Vardiman J, editors. 2001. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press.
10. Kurokawa Y, Honma K, Takemasa I, Nakamori S, Kita-Matsuo H, Motoori M, Nagano H, Dono K, Ochiya T, Monden M, Kato K. 2006. Central genetic alterations common to all HCV-positive, HBV-positive and non-B, non-C hepatocellular carcinoma: A new approach to identify novel tumor markers. Int J Oncol 28:383-391.
11. Lenz G, Nagel I, Siebert R, Roschke AV, Sanger W, Wright GW, Dave SS, Tan B, Zhao H, Rosenwald A, Muller-Hermelink HK, Gascoyne RD, Campo E, Jaffe ES, Smeland EB, Fisher RI, Kuehl WM, Chan WC, Staudt LM. 2007. Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell-like diffuse large B cell lymphoma. J Exp Med 204:633-643.
12. Lepretre S, Buchonnet G, Stamatoullas A, Lenain P, Duval C, d'Anjou J, Callat MP, Tilly H, Bastard C. 2000. Chromosome abnormalities in peripheral T-cell lymphoma. Cancer Genet Cytogenet 117:71-79.
13. Lopez M, Aoubala M, Jordier F, Isnardon D, Gomez S, Dubreuil P. 1998. The human poliovirus receptor related 2 protein is a new hematopoietic/endothelial homophilic adhesion molecule. Blood 92:4602-4611.
14. Martin-Subero JI, Wlodarska I, Bastard C, Picquenot JM, Hoppner J, Giefing M, Klapper W, Siebert R. 2006. Chromosomal rearrangements involving the BCL3 locus are recurrent in classical Hodgkin and peripheral T-cell lymphoma. Blood 108:401-402.
15. Martin-Subero JI, Ibbotson R, Klapper W, Michaux L, Callet-Bauchu E, Berger F, Calasanz MJ, Wolf-Peeters C, Dyer MJ, Felman P, Gardiner A, Gascoyne RD, Gesk S, Harder L, Horsman DE, Kneba M, Kuppers R, Majid A, Parry-Jones N, Ritgen M, Salido M, Sole F, Thiel G, Wacker HH, Oscier D, Wlodarska I, Siebert R. 2007. A comprehensive genetic and histopathologic analysis identifies two subgroups of B-cell malignancies carrying a t(14;19)(q32;q13) or variant BCL3-cranslocation. Leukemia 21:1532-1544.
16. Mathas S, Johrens K, Joos S, Lietz A, Hummel F, Janz M, Jundt F, Anagnostopoulos I, Bommert K, Lichter P, Stein H, Scheidereit C, Dorken B. 2005. Elevated NF-κB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large-cell, and other peripheral T-cell lymphomas. Blood 106:4287-4293.
17. McKeithan TW, Takimoto GS, Ohno H, Bjorling VS, Morgan R, Hecht BK, Dube I, Sandberg AA, Rowley JD. 1997. BCL3 rearrangements and t(14;19) in chronic lymphocytic leukemia and other B-cell malignancies: A molecular and cytogenetic study. Genes Chromosomes Cancer 20:64-72.
18. Michaux L, Dierlamm J, Wlodarska I, Bours V, Van den BH, Hagemeijer A. 1997. t(14;19)/BCL3 rearrangements in lymphoproliferative disorders: A review of 23 cases. Cancer Genet Cvtogenet 94:36-43.
19. Mitelman F, editor. 1995. An International System for Human Cytogenetic Nomenclature (1995): Recommendations of the International Standing Committee on Human Cytogenetic Nomenclature, Memphis, Tennessee, October 1994. Basel, Switzeland: S. Karger.
20. Przybylski GK, Wanzeck J, Verschuren MC, van Dongen JJ, Serke S, Schmidt CA. 2003. Identification of a new cluster of T-cell receptor δ recombining elements. Immunology 108:16-23.
21. Rabbitts TH. 1994. Chromosomal translocations in human cancer. Nature 372:143-149.
22. Rack KA, Cornelis F, Radford-Weiss I, Bernheim A, Harrison CJ, Hermine O, Prieur M, Vekemans M, Macintyre EA. 1997. A chromosome 14q11/TCR α/δ specific yeast artificial chromosome improves the detection rate and characterization of chromosome abnormalities in T-lymphoproliferative disorders. Blood 90:1233-1240.
23. Robinson HM, Taylor KE, Jalali GR, Cheung KL, Harrison CJ, Moorman AV 2004. t(14;19)(q32;q13): A recurrent translocation in B-cell precursor acute lymphoblastic leukemia. Genes Chromosomes Cancer 39:88-92.
24. Schlegelberger B, Himmler A, Godde E, Grote W, Feller AC, Lennert K. 1994. Cytogenetic findings in peripheral T-cell lymphomas as a basis for distinguishing low-grade and high-grade lymphomas. Blood 83:505-511.
25. Soma LA, Gollin SM, Remstein ED, Ketterling RP, Flynri HC, Rajasenan KK, Swerdlow SH. 2006. Splenic small B-cell lymphoma with IGH/BCL3 translocation. Hum Pathol 37:218-230.
26. Verschuren MC, Wolvers-Tettero IL, Breit TM, Noordzij J, van Wering ER, van Dongen JJ. 1997. Preferential rearrangements of the T cell receptor-δ-deleting elements in human T cells. J Immunol 158:1208-1216.
27. Willis TG, Jadayel DM, Coignet LJ, Abdul-Rauf M, Treleaven JG, Catovsky D, Dyer MJ. 1997. Rapid molecular cloning of rearrangements of the IGHJ locus using long-distance inverse polymerase chain reaction. Blood 90:2456-2464.